<DOC>
	<DOCNO>NCT02094755</DOCNO>
	<brief_summary>Critical Limb Ischemia ( CLI ) define limb pain occur rest , impend limb loss cause severe compromise blood flow affect extremity . CLI major cause death disability ( secondary myocardial infarction , stroke amputation ) . The mortality patient CLI approach 25 % 50 % one five year respectively . High on-treatment platelet reactivity ( HPR ) patient treat aspirin clopidogrel ( previously refer `` resistance '' ) associate increase risk recurrent cardiovascular event percutaneous coronary intervention acute coronary syndrome . The prevalence significance HPR patient critical limb ischemia treat aspirin and/or clopidogrel know . The investigator project aim investigate prevalence HPR ( aspirin clopidogrel ) one hundred patient diagnosis critical limb ischemia encounter University Southern California affiliate hospital ( Los Angeles County Hospital Keck Hospital USC ) .</brief_summary>
	<brief_title>ASA/Plavix Resistance CLI</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>EXPERIMENTAL GROUP : Patients diagnosis CLI uninterrupted treatment aspirin and/or clopidogrel least one week test . CONTROL GROUP : 10 normal volunteer without know comorbidities Chronic use nonsteroidal antiinflammatory drug , thrombocytopenia ( platelet count &lt; 100 × 103/μl ) , use oral anticoagulant ( warfarin ) , GPIIb/IIIa inhibitor , fibrinolytic drug within 30 day test . Any documented history hypercoaguable state history medication noncompliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>critical limb ischemia , High on-treatment platelet reactivity , HPR , aspirin , clopidogrel</keyword>
</DOC>